Drug efflux by a small multidrug resistance protein is inhibited by a transmembrane peptide

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 3911-3916

  Poulsen, Bradley E ^a,b   Deber, Charles M ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ETHIDIUM BROMIDE; HSMR PROTEIN; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PEPTIDE; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CHIRALITY; DIMERIZATION; FLUORESCENCE; HALOBACTERIUM SALINARUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; BIOLOGICAL TRANSPORT; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HALOBACTERIUM SALINARUM; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MEMBRANE PROTEINS; PEPTIDES;

EID: 84862544656     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00158-12     Document Type: Article

References (44)

1. Bay DC, Rommens KL, Turner RJ. 2008. Small multidrug resistance proteins: a multidrug transporter family that continues to grow. Biochim. Biophys. Acta 1778:1814-1838.
2. Bennasroune A, et al. 2004. Transmembrane peptides as inhibitors of ErbB receptor signaling. Mol. Biol. Cell 15:3464-3474.
3. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
4. Butler PJ, Ubarretxena-Belandia I, Warne T, Tate CG. 2004. The Escherichia coli multidrug transporter EmrE is a dimer in the detergent-solubilised state. J. Mol. Biol. 340:797-808.
5. Caputo GA, et al. 2008. Computationally designed peptide inhibitors of protein-protein interactions in membranes. Biochemistry 47:8600-8606.
6. Chen YJ, et al. 2007. X-ray structure of EmrE supports dual topology model. Proc. Natl. Acad. Sci. U. S. A. 104:18999-19004.
7. Cohen T, Cohen SJ, Antonovsky N, Cohen IR, Shai Y. 2010. HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog. 6:e1001085. doi:10.1371/journal. ppat.1001085.
8. Elbaz Y, Salomon T, Schuldiner S. 2008. Identification of a glycine motif required for packing in EmrE, a multidrug transporter from Escherichia coli. J. Biol. Chem. 283:12276-12283.
9. Elbaz Y, Steiner-Mordoch S, Danieli T, Schuldiner S. 2004. In vitro synthesis of fully functional EmrE, a multidrug transporter, and study of its oligomeric state. Proc. Natl. Acad. Sci. U. S. A. 101:1519-1524.
10. Fink A, Sal-Man N, Gerber D, Shai Y. 2012. Transmembrane domains interactions within the membrane milieu: principles, advances and challenges. Biochim. Biophys. Acta 1818:974-983.
11. Glukhov E, Stark M, Burrows LL, Deber CM. 2005. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J. Biol. Chem. 280:33960-33967.
12. Grinius LL, Goldberg EB. 1994. Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump. J. Biol. Chem. 269:29998-30004.
13. Hancock RE. 1997. Peptide antibiotics. Lancet 349:418-422.
14. Harikumar KG, Pinon DI, Miller LJ. 2007. Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor. J. Biol. Chem. 282:30363-30372.
15. Heir E, Sundheim G, Holck AL. 1999. Identification and characterization of quaternary ammonium compound resistant staphylococci from the food industry. Int. J. Food Microbiol. 48:211-219.
16. Hessa T, et al. 2007. Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature 450:1026-1030.
17. Korkhov VM, Tate CG. 2008. Electron crystallography reveals plasticity within the drug binding site of the small multidrug transporter EmrE. J. Mol. Biol. 377:1094-1103.
18. LePecq JB, Paoletti C. 1967. A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. J. Mol. Biol. 27:87-106.
19. Littlejohn TG, et al. 1992. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 74:259-265.
20. Masaoka Y, et al. 2000. A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis. J. Bacteriol. 182:2307-2310.
21. Melnyk RA, et al. 2003. Polar residue tagging of transmembrane peptides. Biopolymers 71:675-685.
22. Morrison EA, et al. 2012. Antiparallel EmrE exports drugs by exchanging between asymmetric structures. Nature 481:45-50.
23. Murakami S, Nakashima R, Yamashita E, Yamaguchi A. 2002. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587-593.
24. Muth TR, Schuldiner S. 2000. A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE. EMBO J. 19:234-240.
25. Ng DP, Poulsen BE, Deber CM. 2012. Membrane protein misassembly in disease. Biochim. Biophys. Acta 1818:1115-1122.
26. Nikaido H. 2009. Multidrug resistance in bacteria. Annu. Rev. Biochem. 78:119-146.
27. Ninio S, Schuldiner S. 2003. Characterization of an archaeal multidrug transporter with a unique amino acid composition. J. Biol. Chem. 278:12000-12005.
28. Nishino K, Yamaguchi A. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183:5803-5812.
29. Partridge AW, Melnyk RA, Yang D, Bowie JU, Deber CM. 2003. A transmembrane segment mimic derived from Escherichia coli diacylglycerol kinase inhibits protein activity. J. Biol. Chem. 278:22056-22060.
30. Paulsen IT, et al. 1993. The 3= conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob. Agents Chemother. 37:761-768.
31. Poulsen BE, Cunningham F, Lee KK, Deber CM. 2011. Modulation of substrate efflux in bacterial small multidrug resistance proteins by mutations at the dimer interface. J. Bacteriol. 193:5929-5935.
32. Poulsen BE, Rath A, Deber CM. 2009. The assembly motif of a bacterial small multidrug resistance protein. J. Biol. Chem. 284:9870-9875.
33. Quintana FJ, Gerber D, Kent SC, Cohen IR, Shai Y. 2005. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J. Clin. Invest. 115:2149-2158.
34. Rath A, Melnyk RA, Deber CM. 2006. Evidence for assembly of small multidrug resistance proteins by a "two-faced" transmembrane helix. J. Biol. Chem. 281:15546-15553.
35. Rath A, Tulumello DV, Deber CM. 2009. Peptide models of membrane protein folding. Biochemistry 48:3036-3045.
36. Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM. 2009. Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc. Natl. Acad. Sci. USA 106:1760-1765.
37. Sal-Man N, Gerber D, Shai Y. 2004. Hetero-assembly between all-L-and all-D-amino acid transmembrane domains: forces involved and implication for inactivation of membrane proteins. J. Mol. Biol. 344:855-864.
38. Schuldiner S. 2009. EmrE, a model for studying evolution and mechanism of ion-coupled transporters. Biochim. Biophys. Acta 1794:748-762.
39. Soskine M, Steiner-Mordoch S, Schuldiner S. 2002. Crosslinking of membrane- embedded cysteines reveals contact points in the EmrE oligomer. Proc. Natl. Acad. Sci. U. S. A. 99:12043-12048.
40. Stark M, Liu LP, Deber CM. 2002. Cationic hydrophobic peptides with antimicrobial activity. Antimicrob. Agents Chemother. 46:3585-3590.
41. Tate CG, Kunji ER, Lebendiker M, Schuldiner S. 2001. The projection structure of EmrE, a proton-linked multidrug transporter from Escherichia coli, at 7 A resolution. EMBO J. 20:77-81.
42. Tate CG, Ubarretxena-Belandia I, Baldwin JM. 2003. Conformational changes in the multidrug transporter EmrE associated with substrate binding. J. Mol. Biol. 332:229-242.
43. Tulumello DV, Deber CM. 2011. Positions of polar amino acids alter interactions between transmembrane segments and detergents. Biochemistry 50:3928-3935.
44. Ubarretxena-Belandia I, Baldwin JM, Schuldiner S, Tate CG. 2003. Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer. EMBO J. 22:6175-6181.